Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
MarcS's Profile
Displaying 951-1000 of 1133 result(s).
CYDY CytoDyn Inc
12/18/2020 7:36:37 PM
It was in essence non-dilutive at t (2)
CYDY CytoDyn Inc
12/18/2020 7:02:19 PM
Less than a PENNY (one cent) diluti (3)
CYDY CytoDyn Inc
12/18/2020 6:48:56 PM
Appears to be the conversion of $7. (5)
CYDY CytoDyn Inc
12/18/2020 11:47:47 AM
CYDY versus MESO article: https://e (2)
CYDY CytoDyn Inc
12/17/2020 2:11:34 AM
By Chris Sandburg: https://insiderf (2)
CYDY CytoDyn Inc
12/16/2020 7:45:59 PM
No, failure to sell the entire stoc (5)
CYDY CytoDyn Inc
12/16/2020 5:33:07 PM
Until the FDA approves it, we have (8)
CYDY CytoDyn Inc
12/15/2020 12:49:35 AM
No, that one is the original. The r (1)
CYDY CytoDyn Inc
12/14/2020 5:10:53 PM
Pure manipulation. I bought shares
CYDY CytoDyn Inc
12/14/2020 1:03:04 AM
A dividend will stick it to the sho (8)
CYDY CytoDyn Inc
12/10/2020 1:01:56 AM
As the letter stated they share the (4)
CYDY CytoDyn Inc
12/09/2020 11:52:05 PM
Plus, if they own that number of sh (10)
CYDY CytoDyn Inc
12/08/2020 12:05:00 AM
Question you have to ask: Who got l (5)
CYDY CytoDyn Inc
12/07/2020 10:38:38 PM
Leronlimab is administered by subcu (4)
CYDY CytoDyn Inc
12/07/2020 9:52:25 PM
XW013K6 Google it. (2)
CYDY CytoDyn Inc
12/07/2020 9:45:39 PM
Leronlimab is on the New 2021 CMS L (6)
CYDY CytoDyn Inc
12/07/2020 2:54:05 PM
Most people using stop losses will (6)
CYDY CytoDyn Inc
12/06/2020 7:18:09 PM
The New York Times: Doctors Are Ske (5)
CYDY CytoDyn Inc
12/05/2020 2:48:46 PM
Ancient history by current Pharma a (4)
CYDY CytoDyn Inc
12/05/2020 12:46:10 PM
Your analogy is off. CYDY insiders (9)
CYDY CytoDyn Inc
12/04/2020 7:00:06 PM
Do you know when it was posted to t (1)
CYDY CytoDyn Inc
12/04/2020 6:51:17 PM
I just posted sort of an answer to (3)
CYDY CytoDyn Inc
12/04/2020 6:40:54 PM
I think it is unusual to post an ar (8)
CYDY CytoDyn Inc
12/04/2020 4:37:56 PM
What do you all make of the fact th (2)
CYDY CytoDyn Inc
12/03/2020 4:08:20 PM
Not a chartist, but a nice little H (3)
CYDY CytoDyn Inc
12/03/2020 3:09:56 PM
Actually, the CC PR was short, dire (4)
CYDY CytoDyn Inc
12/02/2020 7:15:23 PM
Paraphrasing: Dr. Bruce Patterson s (2)
CYDY CytoDyn Inc
12/02/2020 7:08:32 PM
Should have read: Dr. Patterson sai
CYDY CytoDyn Inc
12/02/2020 6:54:41 PM
Just reporting what Dr. Bruce Patte
CYDY CytoDyn Inc
12/02/2020 6:47:29 PM
Speaking of vaccines: Dr. Patterson (1)
CYDY CytoDyn Inc
12/02/2020 11:49:50 AM
It's buried in the latest PR this m (1)
CYDY CytoDyn Inc
12/02/2020 9:51:33 AM
End of next week is 18 days past th
CYDY CytoDyn Inc
11/30/2020 7:39:52 PM
Relief changed their "Primary Outco (5)
CYDY CytoDyn Inc
11/30/2020 11:39:49 AM
If your investment thesis is to fol (2)
CYDY CytoDyn Inc
11/25/2020 9:21:28 PM
The AstraZeneca Covid Vaccine Data (4)
CYDY CytoDyn Inc
11/25/2020 3:44:20 PM
Dr. Otto Yang at UCLA is versed in
CYDY CytoDyn Inc
11/23/2020 5:16:24 PM
Isn't this something that might hel
CYDY CytoDyn Inc
11/23/2020 2:00:03 PM
OWS is another interesting play on (7)
CYDY CytoDyn Inc
11/23/2020 1:41:14 PM
Many of us here and on Yahoo have b (6)
CYDY CytoDyn Inc
11/23/2020 11:05:10 AM
CyDy will probably get Canada or UK (6)
CYDY CytoDyn Inc
11/23/2020 10:50:17 AM
You will need to ask him at the nex (1)
CYDY CytoDyn Inc
11/21/2020 8:23:28 PM
They should immediately yesterday a (4)
CYDY CytoDyn Inc
11/21/2020 7:54:23 PM
Isn't this like an OXYMORON?: "Casi (6)
CYDY CytoDyn Inc
11/20/2020 9:48:33 PM
Don't think it's paid. It's a symbi (4)
CYDY CytoDyn Inc
11/20/2020 6:45:30 PM
It does link to the recent Yang man (3)
CYDY CytoDyn Inc
11/20/2020 6:24:31 PM
Study: New Blockbuster Drug Treatme (8)
CYDY CytoDyn Inc
11/20/2020 3:25:43 PM
I am saying the effective trial siz (2)
CYDY CytoDyn Inc
11/20/2020 2:59:22 PM
But is not the relevant patient pop (2)
CYDY CytoDyn Inc
11/20/2020 12:55:08 PM
CytoDyn has now put a link up on th
CYDY CytoDyn Inc
11/20/2020 12:24:07 PM
The contract (or an identical facsi
Go to page:
  • << First
  • < Previous
  • 19
  • 20
  • Next >

Recent Articles

  • Challenges of Manufacturing Smartphones in America Explored
  • Air Canada Faces Flight Operations Suspension Amid Negotiation
  • Centene Corporation Class Action Lawsuit: What Investors Need to Know
  • Investors Investigate LifeMD, Inc. After Recent Earnings Drop
  • Exciting Travel Deals Now Available in Germany for Adventurers
  • Lockheed Martin Shareholders Should Act Now Amid Lawsuit Risk
  • Sarepta Therapeutics: Join the Class Action for Compensation
  • Petco Health and Wellness Faces Class Action Deadline Soon
  • Dogecoin Investors Showcase Rugged Optimism Amid Market Decline
  • Tim Cook's Gift to Trump Reflects Apple's $100 Billion Pledge
  • AT&T Inc. Reveals $177 Million Settlement for Data Breaches
  • Overcoming the Challenges of Connected TV Advertising Today
  • The Impact of AI on Financial Markets: A Cautionary Tale
  • Kevin O'Leary's Innovative Executive Hiring Model Explained
  • New Talks Aim for Lasting Peace as Tensions Escalate
  • Innovative AI Platform from GridStrat Enhances Market Strategies
  • New Chip Export Dynamics Shaping Global Semiconductor Market
  • Investors Urged to Act as Hims & Hers Health Faces Legal Scrutiny
  • Petco Investors Examined for Claims Amid Stock Decline
  • Transforming Work: AI Replaces Soul-Crushing Jobs Amid Growth
  • Investigation Launched on Investor Claims against Centene Corp
  • John Paulson Expands Portfolio with Alphabet and Gold Miner
  • ExpandCommunication Revolutionizes Public Relations with AI
  • Important Investor Update on Sarepta Therapeutics' Safety Claims
  • Rillet Secures $70M Investment to Innovate AI in Accounting
  • Coatue Management's Strategic Bet on AI and Cloud Growth
  • Celebrate Nature With the New Luna Moth Stamp Release
  • Lineage, Inc. Investors: Important Class Action Deadline Ahead
  • Legal Action Update: Investors Target Novo and Others
  • Jim Cramer Encourages Investors to Stay Confident Amid Market Swings
  • Centene Corporation Securities Class Action: Key Details for Investors
  • Explore the Hidden Industries Booming Under the Radar
  • Understanding Relevant Class Actions Against Major Firms
  • Replimune Group, Inc. Investors Should Take Action Now
  • Greenlight Capital's Strategic Moves: Insights into Q2 2025
  • Class Action Alert: Reddit Investors Must Act Before Deadline
  • Understanding the Legal Activity Surrounding Hims Inc. Shares
  • Sarepta Therapeutics Faces Lawsuit: Take Action Before Deadline
  • Alto Neuroscience Shareholder Class Action: Important Updates
  • Datumo's $15.5 Million Fund Boosts AI Evaluation Tools
  • IRS Clarifies No New Stimulus Checks Will Be Issued This Year
  • CTO Realty Growth Investors: Act Now for Class Action Rights
  • Danielle Panabaker's Crossover Experience: Pay Issues Revealed
  • New Forever Stamp Celebrates Legacy of Former President Carter
  • XPPen Marks 20 Years of Innovation and Creativity in Art
  • Investigation Launched for Investors of GSK plc Amid Concerns
  • Unraveling Investor Concerns Involving Confluent, Inc. Stock
  • Investigation into Neogen Corporation Raises Concerns for Investors
  • Class Action Filed Against Alto Neuroscience Over IPO Misrepresentation
  • Class Action Lawsuit Announced Against Hims & Hers Health, Inc.
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site